1	La	el	DA0FS0	-	-	0-2	133(4)_ANS_clinical_caseMIR	SENT1	-	-
2	determinaci贸n	determinaci贸n	NCFS000	C0242485	procedimiento	3-16	133(4)_ANS_clinical_caseMIR	SENT1	-	-
3	de	de	SPS00	C0332285	atributo	17-19	133(4)_ANS_clinical_caseMIR	SENT1	-	-
4	anticuerpos	anticuerpo	NCMP000	C0003241	sustancia	20-31	133(4)_ANS_clinical_caseMIR	SENT1	-	-
5	antiplaquetarios	antiplaquetario	AQ0MP0	-	-	32-48	133(4)_ANS_clinical_caseMIR	SENT1	-	-
6	no	no	RN	C1298908	calificador	49-51	133(4)_ANS_clinical_caseMIR	SENT1	-	-
7	es	ser	VSIP3S0	-	-	52-54	133(4)_ANS_clinical_caseMIR	SENT1	-	-
8	precisa	preciso	AQ0FS0	C0443131	calificador	55-62	133(4)_ANS_clinical_caseMIR	SENT1	-	-
9	para	para	SPS00	C0521125	calificador	63-67	133(4)_ANS_clinical_caseMIR	SENT1	-	-
10	establecer	establecer	VMN0000	-	-	68-78	133(4)_ANS_clinical_caseMIR	SENT1	-	-
11	el	el	DA0MS0	-	-	79-81	133(4)_ANS_clinical_caseMIR	SENT1	-	-
12	diagn贸stico	diagn贸stico	NCMS000	C0011900	entidad_observable	82-93	133(4)_ANS_clinical_caseMIR	SENT1	-	-
13	.	.	Fp	-	-	93-94	133(4)_ANS_clinical_caseMIR	SENT1	-	-

